Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Claxton

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Blood|January 1, 1994
Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosomeL Nagarajan, J Zavadil, D Claxton, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Bone Marrow Transplantation|September 11, 2001
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I studyF Ravandi, H Kantarjian, A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphomaI F Khouri, J Romaguera, H Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignanciesI F Khouri, M Keating, M Körbling, et al.
Mutation Research|December 7, 2000
Mutagenicity in lung of big Blue((R)) mice and induction of tandem-base substitutions in Salmonella by the air pollutant peroxyacetyl nitrate (PAN): predicted formation of intrastrand cross-linksD M DeMarini, M L Shelton, M J Kohan, et al.
Blood|August 10, 1999
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, T L Smith, J Folloder, et al.
American Journal of Hematology|July 10, 2001
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemiaS Bibawi, D Abi-Said, L Fayad, et al.
Blood|June 15, 1997
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapyS Giralt, E Estey, M Albitar, et al.
Bone Marrow Transplantation|March 30, 2004
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphomaU Popat, C Hosing, R M Saliba, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Blood|January 1, 1994
Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosomeL Nagarajan, J Zavadil, D Claxton, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Bone Marrow Transplantation|September 11, 2001
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I studyF Ravandi, H Kantarjian, A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphomaI F Khouri, J Romaguera, H Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignanciesI F Khouri, M Keating, M Körbling, et al.
Mutation Research|December 7, 2000
Mutagenicity in lung of big Blue((R)) mice and induction of tandem-base substitutions in Salmonella by the air pollutant peroxyacetyl nitrate (PAN): predicted formation of intrastrand cross-linksD M DeMarini, M L Shelton, M J Kohan, et al.
Blood|August 10, 1999
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, T L Smith, J Folloder, et al.
American Journal of Hematology|July 10, 2001
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemiaS Bibawi, D Abi-Said, L Fayad, et al.
Blood|June 15, 1997
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapyS Giralt, E Estey, M Albitar, et al.
Bone Marrow Transplantation|March 30, 2004
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphomaU Popat, C Hosing, R M Saliba, et al.
Pageof 15